Found: 5
Select item for more details and to access through your institution.
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in Neuroblastoma.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2320, doi. 10.3390/cancers16132320
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Fluorescent Bryostatin Analogues.
- Published in:
- ChemBioChem, 2018, v. 19, n. 8, p. 877, doi. 10.1002/cbic.201700655
- By:
- Publication type:
- Article
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 448, p. 1, doi. 10.1126/scitranslmed.aan4470
- By:
- Publication type:
- Article
Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics.
- Published in:
- 2015
- By:
- Publication type:
- journal article